Skip to main content

Table 4 Total production of group 1 and group 2 companies

From: Longitudinal study of the impact of three major regulations on the Korean pharmaceutical industry in the last 30 years

 

Production amount (Bill. )

1988–1993

1994–1998

1999–2002

2003–2007

2008–2012

2013–2017

Total

Group 1 (CAGR)

10 809 (13.25%)

15 582 (6.45%)

14 697 (4.70%)

24 561 (9.98%)

35 537 (0.59%)

36 837 (4.37%)

138 022 (6.90%)

Group 2 (CAGR)

9500 (16.98%)

15 358 (4.44%)

13 878 (4.30%)

24 338 (8.11%)

31 795 (2.66%)

40 034 (5.03%)

134 904 (8.40%)

Difference (CAGR)

1309 (−13.78%)

224 (−1.50%)

819 (−5.90%)

223 (−0.90%)

3742 (−11.80%)

(−)3197 (7.98%)

3118 (−2.30%)

  1. CAGR: compound annual growth rate